ATHE Neutral Sentiment Score: 45/100
ASX ANNOUNCEMENT 17 February 2025 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), unde
Tuesday, February 18, 2025 1 min read
Key Takeaway: Alterity Therapeutics Limited has issued a notice under section 708A(5)(e) of the Corporations Act regarding new shares issued. The announcement states that a total of 1,165,841,830 fully paid ordinary shares have been issued on 17 February 2025. This notice complies with legal requirements pertaining to the reporting of securities by the company. No further details regarding the implications or reasons behind the issuance are provided in this notice.
Full Press Release Details
Notice Under Section 708A(5)(e) of the Corporations
This notice is given by Alterity Therapeutics
Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e) of the
Corporations Act 2001 (Cth) (Corporations Act).
| Details of securities issued |
| Type: | Shares |
| Class/Description: | Fully paid ordinary shares |
| ASX Code: | ATH |
| Date of Issue: | 17 February 2025 |
| Number Issued: | 1,165,841,830 |
The Company gives notice pursuant to section 708A(5)(e)
of the Corporations Act that:
| /s/ Abby Macnish Niven | |
| Abby Macnish Niven | |
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria